Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY97.10 CNY
Change Today -2.89 / -2.89%
Volume 3.2M
002424 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 2:11 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

guizhou bailing group phar-a (002424) Snapshot

Open
CNY100.01
Previous Close
CNY99.99
Day High
CNY100.99
Day Low
CNY95.71
52 Week High
05/28/15 - CNY112.97
52 Week Low
06/4/14 - CNY22.24
Market Cap
45.7B
Average Volume 10 Days
4.0M
EPS TTM
CNY0.71
Shares Outstanding
470.4M
EX-Date
06/4/14
P/E TM
137.2x
Dividend
--
Dividend Yield
0.21%
Current Stock Chart for GUIZHOU BAILING GROUP PHAR-A (002424)

Related News

No related news articles were found.

guizhou bailing group phar-a (002424) Related Businessweek News

No Related Businessweek News Found

guizhou bailing group phar-a (002424) Details

Guizhou Bailing Group Pharmaceutical Co., Ltd. manufactures and distributes medicines. The company manufactures Miao ethno medicines; and cultivates and sells Chinese herbal medicine materials. Its medicine products primarily include syrups, and capsules used in the treatment of cardiovascular and cerebrovascular diseases, cough, and cold. The company is also involved in the production and sale of purified water. Guizhou Bailing Group Pharmaceutical Co., Ltd. is based in Anshun, China.

guizhou bailing group phar-a (002424) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

guizhou bailing group phar-a (002424) Key Developments

Guizhou Bailing Group Pharmaceutical Co., Ltd. and Tencent Holdings Team Up for Online Medical Service of Chronic Diseases

Guizhou Bailing Group Pharmaceutical Co. Ltd. and Tencent Holdings have reached cooperation for online medical service of chronic diseases, making full use of rich user data, mature cloud computing capacity, strong social networking platform and media platform of Tencent Holdings to bolster up application, information management and medical service of chronic diseases. Both sides will team up for long term, with Guizhou Bailing Group taking charge of developing, making and testing drugs for chronic diseases, offering medical instruments and distance medical consultancy, management and diagnosis service.

Guizhou Bailing Group Pharmaceutical Co.,Ltd.(SZSE:002424) added to Shenzhen Stock Exchange Component A Share Index

Guizhou Bailing Group Pharmaceutical Co.,Ltd. has been added to Shenzhen Stock Exchange Component A Share Index.

Guizhou Bailing Group Pharmaceutical Co.,Ltd.(SZSE:002424) added to Shenzhen Stock Exchange Component Index

Guizhou Bailing Group Pharmaceutical Co.,Ltd. has been added to Shenzhen Stock Exchange Component Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002424:CH CNY97.10 CNY -2.89

002424 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002424.
View Industry Companies
 

Industry Analysis

002424

Industry Average

Valuation 002424 Industry Range
Price/Earnings 100.0x
Price/Sales 29.5x
Price/Book 19.6x
Price/Cash Flow 143.1x
TEV/Sales 28.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUIZHOU BAILING GROUP PHAR-A, please visit www.gzbl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.